Incidence and clinicopathological features of differentiated high-grade thyroid carcinomas: an institutional experience
SI Jeong, W Kim, HW Yu, JY Choi, CH Ahn… - Endocrine …, 2023 - Springer
Differentiated high-grade thyroid carcinoma (DHGTC) is a new entity in the 2022 WHO
classification. We aimed to investigate the incidence and clinicopathological features of …
classification. We aimed to investigate the incidence and clinicopathological features of …
The Long Journey towards Personalized Targeted Therapy in Poorly Differentiated Thyroid Carcinoma (PDTC): A Case Report and Systematic Review
O Violetis, P Konstantakou, A Spyroglou… - Journal of Personalized …, 2024 - mdpi.com
Background: Poorly differentiated thyroid carcinoma (PDTC) has an intermediate prognosis
between indolent well-differentiated thyroid carcinoma (TC) and anaplastic carcinoma …
between indolent well-differentiated thyroid carcinoma (TC) and anaplastic carcinoma …
Management of Poorly Differentiated Thyroid Cancer and Differentiated High-Grade Thyroid Carcinoma
IS Alam, KN Patel - Surgical Clinics, 2024 - surgical.theclinics.com
Thyroid carcinoma of follicular cell origin exists on a histopathologic and clinical spectrum.
On one end, up to 87% of thyroid cancers are well-differentiated and have a very favorable …
On one end, up to 87% of thyroid cancers are well-differentiated and have a very favorable …
Cytologic features of differentiated high‐grade thyroid carcinoma: A multi‐institutional study of 40 cases
Background Differentiated high‐grade thyroid carcinoma (DHGTC) is recently recognized by
the World Health Organization (WHO) as a subgroup of thyroid carcinomas with high‐grade …
the World Health Organization (WHO) as a subgroup of thyroid carcinomas with high‐grade …
Differentiated high grade thyroid carcinomas: Diagnostic consideration and clinical features
IT Resta, MA Gubbiotti, KT Montone, VA Livolsi… - Human Pathology, 2024 - Elsevier
Background Differentiated high-grade thyroid carcinomas (DHGTCs) are a new diagnostic
entity most recently defined in the 2022 World Health Organization's (WHO) Classification of …
entity most recently defined in the 2022 World Health Organization's (WHO) Classification of …
Current evidences in poorly differentiated thyroid carcinoma: a systematic review and subsection meta-analysis for clinical decision making
S Chatterjee, M Mair, AR Shaha, V Paleri, S Sawhney… - Endocrine, 2024 - Springer
Background Poorly differentiated thyroid carcinoma (PDTC) is a distinct entity with
intermediate prognosis between indolent follicular thyroid cancers and anaplastic …
intermediate prognosis between indolent follicular thyroid cancers and anaplastic …
RAS-Mutant Follicular Thyroid Tumors: A Continuous Challenge for Pathologists
JC Hernandez-Prera, BM Wenig - Endocrine Pathology, 2024 - Springer
The classification of thyroid nodules, particularly those with a follicular growth pattern, has
significantly evolved. These tumors, enriched with RAS or RAS-like mutations, remain …
significantly evolved. These tumors, enriched with RAS or RAS-like mutations, remain …
Uncommon molecular alterations in follicular-derived thyroid carcinoma: A single institution study
BA Alexiev, ER Vormittag-Nocito, J Lorch… - … -Research and Practice, 2024 - Elsevier
Thyroid carcinomas are the most common endocrine malignancy and commonly have
alterations in the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 …
alterations in the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 …
[HTML][HTML] Clinical and Paraclinical Considerations Regarding ki67's Role in the Management of Differentiated Thyroid Carcinoma—A Literature Review
C Peștean, A Pavel, D Piciu - Medicina, 2024 - mdpi.com
Background and Objectives: The ki67 nuclear protein is a tool for diagnosis and prognosis in
oncology that is used to evaluate cell proliferation. Differentiated thyroid carcinoma is …
oncology that is used to evaluate cell proliferation. Differentiated thyroid carcinoma is …
[HTML][HTML] A Comprehensive Review and Insights into the New Entity of Differentiated High-Grade Thyroid Carcinoma
AS Harahap, RS Roren, S Imtiyaz - Current Oncology, 2024 - mdpi.com
Differentiated high-grade thyroid carcinoma (DHGTC) is a new subset within the spectrum of
thyroid malignancies. This review aims to provide a comprehensive overview of DHGTC …
thyroid malignancies. This review aims to provide a comprehensive overview of DHGTC …